PET imaging of CD8 T lymphocyte recruitment induced by radiotherapy locally and remotely

2024-517640-57-01 Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 24 Jan 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 20
Countries 1
Sites 1

Patients with polymetastatic solid cancers.

Key facts

Sponsor
Commissariat a l'Energie Atomique et aux Energies Alternatives
Participant type
Patients
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
24 Jan 2025 → ongoing
Decision date (initial)
2025-01-24
Transition trial
Yes
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

External identifiers

EU CT number
2024-517640-57-01
EudraCT number
2020-005867-30

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Patients with polymetastatic solid cancers.

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Commissariat a l'Energie Atomique et aux Energies Alternatives

Sponsor organisation
Commissariat a l'Energie Atomique et aux Energies Alternatives
Address
4 Place Du General Leclerc
City
Orsay Cedex
Postcode
91401
Country
France

Scientific contact point

Organisation
Commissariat a l'Energie Atomique et aux Energies Alternatives
Contact name
Charles TRUILLET

Public contact point

Organisation
Commissariat a l'Energie Atomique et aux Energies Alternatives
Contact name
Charles TRUILLET

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 20 1
Rest of world 0

Investigational sites

France

1 site · Ongoing, recruiting
Commissariat a l'Energie Atomique et aux Energies Alternatives
Service Hospitalier Frederic Joliot, 4 Place Du General Leclerc, 91401, Orsay Cedex

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2025-01-24 2025-01-24

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-01-09 France Acceptable
2025-01-24
2025-01-24